Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy
| Conditions: | Pleural Mesothelioma|Peritoneal Mesothelioma |
| Start Date: | June 1, 2010 |
| Phase: | Phase II |
| Status: | Recruiting |
| NCT ID: | NCT01160458 |
| Study Type: | Interventional |
| Intervention: | Drug: IMC-A12 |
| Study Design: | Allocation: Non-Randomized|Control: Active Control|Endpoint Classification: Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 55 |
| Funded By: | NIH |
| First Received: | July 9, 2010 |
| End Date: | April 1, 2012 |
| Last Updated: | January 11, 2011 |
| Last Verified: | June 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
